Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 52

Results For "acquisition"

790 News Found

Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips
Digitisation | April 18, 2023

Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips

Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators


Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology


Calibre Chemicals takes over R&D activities of Tina Life Sciences
News | April 11, 2023

Calibre Chemicals takes over R&D activities of Tina Life Sciences

Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.


CBC Group appoints Abbas Hussain as Operating Partner
People | April 03, 2023

CBC Group appoints Abbas Hussain as Operating Partner

Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions


Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
News | March 29, 2023

Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare

The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies


Emmes acquires Essex Management
News | March 23, 2023

Emmes acquires Essex Management

Essex enriches and complements Emmes’ services


Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr
News | March 17, 2023

Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr

Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore


Pfizer acquires Seagen for US$ 43 billion to battle cancer
News | March 14, 2023

Pfizer acquires Seagen for US$ 43 billion to battle cancer

Proposed combination enhances Pfizer’s position as a leading company in oncology